Loading …
Never Run Out Of Buyers To Sell To.

High sensitivity substrates for enhanced diagnostic test performance. The company's core technology is based on creating three-dimensional features that increase the available area for binding of biomolecules used in-vitro testing with no change in the time to perform the test.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.